The minimum level of CYP2D6 activity for adequate anti-relapse PQ efficacy is unknown.<h4>Methods and findings</h4>We conducted a retrospective, population-based cohort study in the main malaria hotspot of Brazil. This evidence concerns the gene CYP2D6 and malaria.